Dogwood Therapeutics, Inc.
DWTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818844
No open-market purchases or sales by Dogwood Therapeutics, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $6.16M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Dogwood Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- −3 vs. Q3 2023
- Shares held
- 860.2K
- +30.7K (+3.7%) vs. Q3 2023
- Total value
- $493.4K
- −$272.9K (−35.6%) vs. Q3 2023
- New holders
- 1
- 5 more added
- Sold out
- 4
- 2 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DWTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 15 | $6.16M |
| Q1 2026 | 13 | $7.64M |
| Q4 2025 | 10 | $292.0K |
| Q3 2025 | 12 | $299.5K |
| Q2 2025 | 10 | $207.5K |
| Q1 2025 | 13 | $409.8K |
| Q4 2024 | 10 | $76.5K |
| Q3 2024 | 24 | $180.3K |
| Q2 2024 | 24 | $212.0K |
| Q1 2024 | 20 | $324.9K |
| Q4 2023 | 20 | $493.4K |
| Q3 2023 | 23 | $766.3K |
| Q2 2023 | 24 | $1.08M |
| Q1 2023 | 23 | $307.1K |
| Q4 2022 | 27 | $307.7K |
| Q3 2022 | 25 | $485.7K |
| Q2 2022 | 17 | $4.80M |
| Q1 2022 | 15 | $4.91M |
| Q4 2021 | 16 | $4.85M |
| Q3 2021 | 13 | $5.30M |
| Q2 2021 | 14 | $5.58M |
| Q1 2021 | 14 | $5.06M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Dogwood Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 208,883 | $120.1K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 206,697 | $119.0K | 0.00% | +192,698+1,376.5% | Added |
| Geode Capital Management, LLC | 174,469 | $100.3K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 52,828 | $30.4K | 0.00% | 00.0% | Unchanged |
| McCollum Christoferson Group LLC | 37,000 | $21.3K | 0.01% | +3,700+11.1% | Added |
| Raymond James & Associates | 30,000 | $17.3K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 24,035 | $13.8K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 22,760 | $13.1K | 0.00% | +8,319+57.6% | Added |
| Regions Financial Corp | 20,072 | $11.5K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 17,372 | $9.00K | 0.00% | −13,841−44.3% | Reduced |
| Morgan Stanley | 15,000 | $8.63K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 13,982 | $8.04K | 0.00% | +2,500+21.8% | Added |
| Cetera Advisors LLC | 13,560 | $7.80K | 0.00% | 00.0% | Unchanged |
| Wiley Bros.-Aintree Capital, LLC | 11,000 | $6.33K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 6,704 | $3.85K | 0.00% | −2,066−23.6% | Reduced |
| UBS Group AG | 2,600 | $1.50K | 0.00% | +2,600 | New |
| Cutler Group LP | 2,300 | $1.00K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 755 | $434 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 130 | $75 | 0.00% | +6+4.8% | Added |
| Royal Bank of Canada | 56 | $0 | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −102,967−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −27,322−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −22,597−100.0% | Sold out |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −10,284−100.0% | Sold out |